Information used
The workflow brings together retinal photographs from both eyes and patient information, with an image-quality check before analysis.
AtheroSEE AI™
Retinal analysis.
Clinical review.
AtheroSEE AI™ is Software as a Medical Device (SaMD) for hospital outpatient teams, designed to support cardiovascular risk triage using retinal images and patient information.
What the software does.
Prediscan™ develops the analysis and review software. Its intended role is to turn retinal images and patient information into an assessment that supports clinical triage.
Clinical output
An AI-assisted risk assessment intended for review alongside the patient’s history and clinical findings.
Image capture
The camera captures the images used by the software. OIVI manufactures the retinal camera shown in our demonstration; Prediscan™ develops AtheroSEE AI™.
OIVI · Image-capture hardwareAtheroSEE AI™ / The product workflow
From retinal images
to clinical review.
See how retinal images and patient information move through the software to clinical review.
Position the patientScroll to explore
Position the patient
The care team positions the patient at the fundus camera.
Capture retinal images
Retinal photographs provide the input for software analysis.
Check image quality
Review image clarity and retinal detail before proceeding.
Reference photographs, not Prediscan™ patient data.
Mikael Häggström · CC0 · Left source ↗ / Right source ↗
Add patient information
Bring images from both eyes together with the patient’s details.
Review the assessment
The clinician reviews the assessment alongside the patient’s history and other findings, then decides on follow-up.
Product demonstration. Screen values are illustrative.